All lobbying filings

ELEKTA, INC.

Lobbying for ELEKTA, INC.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $70,000.00 expenses · posted Jun 29, 2026

Official filing document

Bills named in this filing 2

HR 1031
Insular Areas College Access Act
S 2021
Close the Round-Tripping Loophole Act

Lobbying activity 7

Trade (domestic/foreign)

General Trade issues USMCA US-EU trade deal US-UK trade deal

Budget/Appropriations

HHS, Labor and Education Appropriations Energy Appropriations

Energy/Nuclear

Gamma Knife/Cobalt-60 Nuclear Material for Medical Use Radioactive Material for Medical Use

Health Issues

Radiation Oncology/ Radiation Therapy Cancer Care General Oncology issues Healthcare reimbursement

Medical/Disease Research/Clinical Labs

Radiation Oncology Cancer Care

Medicare/Medicaid

ROCR legislation H.R. 1031 and S. 2021 Medicare access Medicare reimbursement General Medicare issues Medicaid access Medicaid reimbursement General Medicaid issues

Tariff (miscellaneous tariff bills)

General Tariff issues USMCA US-EU trade agreement US-UK trade agreement

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.